| Global Reporting of Alert Organisms |
| (months were the total number of
strains or the number of resistant isolates are missing were excluded) |
| January to September 1999 |
| |
| Organism
(No. of strains) |
Phenotype
|
resistant |
n |
% |
| Beta-haemolytic Streptococci (4,534
strains) |
| |
Erythromycin |
69 |
1.5% |
| |
Penicillin |
7 |
0.2% |
| |
Glycopeptide |
3 |
0.1% |
| Pneumococci (2,274 strains) |
| |
High level Penicllin |
36 |
1.6% |
| |
Low level Penicillin |
33 |
1.5% |
| |
Erythromycin |
22 |
1.0% |
| |
Glycopeptide |
- |
0.0% |
| Enterococci (6,866 strains) |
| |
Beta-lactamase |
130 |
1.9% |
| |
Glycopeptide |
22 |
0.3% |
| |
High level Gentamicin/Streptomycin |
672 |
9.8% |
| Haemophilus (3,653 strains) |
| |
Ciprofloxacin/4-fluoroquinolone |
1 |
0.0% |
| |
Ceftazidime/3rd or 4th generation
cephalosporin |
3 |
0.1% |
| |
Beta-lactamase |
61 |
1.7% |
| Enterobacteriaceae (22,745 strains) |
| |
Ciprofloxacin/4-fluoroquinolone |
495 |
2.2% |
| |
Gentamicin/1st line aminoglycoside |
612 |
2.7% |
| |
Extended spectrum beta-lactamase |
401 |
1.8% |
| |
Carbapenem |
25 |
0.1% |
| Acinetobacter (1,321 strains) |
| |
Gentamicin/1st line aminoglycoside |
186 |
14.1% |
| |
Carbapenem |
8 |
0.6% |
| Stapylococcus aureus (15425 strains) |
| |
Methicillin |
265 |
1.7% |
| |
MRSA (265 strains) |
| |
Vancomycin |
- |
0.0% |
| |
Teicoplanin |
1 |
0.4% |
| Cholera (8 strains) |
| |
Trimethoprim |
- |
0.0% |
| |
Tetracycline |
- |
0.0% |
| Campylobacter (255 strains) |
| |
Ciprofloxacin |
14 |
5.5% |
| |
2 drug combination |
14 |
5.5% |
| Shigella (104 strains) |
| |
Ciprofloxacin |
- |
0.0% |
| |
2 drug combination |
6 |
5.8% |
| Salmonella (1,294 strains) |
| |
Ciprofloxacin |
1 |
0.1% |
| |
2 drug combination |
15 |
1.2% |
| Neisseria meningitidis (50 strains) |
| |
Penicillin |
- |
0.0% |
| Neisseria gonorrhoea (19 strains) |
| |
Beta-lactamase |
- |
0.0% |
| |
Ciprofloxacin/4-fluoroquinolone |
1 |
5.3% |
| Anaerobes (2,653 strains) |
| |
Augmentin/beta-lactamase inhibitor
combination |
5 |
0.2% |
| |
Carbapenem |
2 |
0.1% |
| |
Metronidazole |
11 |
0.4% |
| Mycobacterium tuberculosis (62
strains) |
| |
2 drug combination |
1 |
1.6% |
| Coagulase negative Staphylococci
(4,391 strains) |
| |
Vancomycin |
1 |
0.0% |
| |
Teicoplanin |
10 |
0.2% |
| Pseudomonas aeruginosa (4,714
strains) |
| |
Ceftazidime/4th generation
cephalosporin |
175 |
3.7% |
| |
Piperacillin/Tazobactam |
188 |
4.0% |
| |
Gentamicin/1st line aminoglycoside |
579 |
12.3% |